Viewing Study NCT01204931



Ignite Creation Date: 2024-05-05 @ 10:52 PM
Last Modification Date: 2024-10-26 @ 10:25 AM
Study NCT ID: NCT01204931
Status: COMPLETED
Last Update Posted: 2016-01-20
First Post: 2010-09-13

Brief Title: Can We Predict Who Has Gastroesophageal Reflux Disease GERD
Sponsor: Vanderbilt University
Organization: Vanderbilt University

Study Overview

Official Title: Can We Predict Who Has GERD Systematic Evaluation of Role of pH Monitoring and the Specific Physiologic pH Parameters in Defining GERD Bravo Impedence and SISAP
Status: COMPLETED
Status Verified Date: 2015-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Gastroesophageal reflux disease GERD is currently defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms andor complications Doctors often diagnose and treat GERD based on symptoms of heartburn and regurgitation In recent years the prevalence of partial or non-response to Proton Pump Inhibitors PPI has increased resulting in diagnostic testing with esophagogastroduodenoscopy EGD or ambulatory pH monitoring Most patients do not have endoscopic evidence for reflux Thus in this group pH monitoring has emerged as an important physiologic test to determine the degree of esophageal acid exposure and to assess the association between patients persistent symptoms and acid reflux events The aims of this study are to assess the sensitivity and specificity of symptom associated indices and determine the best parameter for predicting GERD from a list of conventional pH measurement findings
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None